Coronary Atherosclerosis

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

C
CordisFL - Miami Lakes
1 program
NEVO™ Sirolimus-eluting Coronary Stent SystemN/A1 trial
Active Trials
NCT00606333Terminated394Est. Oct 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CordisNEVO™ Sirolimus-eluting Coronary Stent System

Clinical Trials (1)

Total enrollment: 394 patients across 1 trials

NCT00606333CordisNEVO™ Sirolimus-eluting Coronary Stent System

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions

Start: Mar 2008Est. completion: Oct 2012394 patients
N/ATerminated

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space